TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligase

Biochemical and Biophysical Research Communications

Volumn 383, Issue 2, 2009, Pages 263-268

  Urano, Tomohiko ^a,b   Usui, Takahiko ^a   Takeda, Shizu ^c   Ikeda, Kazuhiro ^b   Okada, Atsushi ^a   Ishida, Yoshiko ^c   Iwayanagi, Takao ^c,d   Otomo, Jun ^c   Ouchi, Yasuyoshi ^a   Inoue, Satoshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c HITACHI LTD   (Japan)

^d NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

E3 ubiquitin ligase; RING finger; Terf; TRIM44

Indexed keywords

HYDROLASE; POLYUBIQUITIN; PROTEASOME INHIBITOR; PROTEINASE; TELOMERIC REPEAT BINDING FACTOR 1; TRIPARTITE MOTIF PROTEIN 44; TRIPARTITE MOTIF PROTEIN 5; UBCH6 ENZYME; UBIQUITIN HYDROLASE; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN SPECIFIC PROTEASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; UBIQUITINATION; ZINC FINGER MOTIF;

ANIMALS; CARRIER PROTEINS; CELL LINE; HUMANS; MALE; MICE; TESTIS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MAMMALIA;

EID: 65049090139     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.010     Document Type: Article

References (22)

1. Nisole S., Stoye J.P., and Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol 3 (2005) 799-808
2. Meroni G., and Diez-Roux G. TRIM/RBCC, a novel class of single protein RING finger E3 ubiquitin ligases. Bioessays 27 (2005) 1147-1157
3. Uchil P.D., Quinlan B.D., Chan W.T., Luna J.M., and Mothes W. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4 (2008) e16
4. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503-533
5. Pickart C.M., and Eddins M.J. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta. 1695 (2004) 55-72
6. Ravid T., and Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 9 (2008) 679-690
7. Trockenbacher A., Suckow V., Foerster J., Winter J., Krauss S., Ropers H.H., Schneider R., and Schweiger S. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat. Genet. 29 (2001) 287-294
8. Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., and Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
9. Urano T., Saito T., Tsukui T., Fujita M., Hosoi T., Muramatsu M., Ouchi Y., and Inoue S. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 417 (2002) 871-875
10. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., and Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446 (2007) 916-920
11. Frosk P., Weiler T., Nylen E., Sudha T., Greenberg C.R., Morgan K., Fujiwara T.M., and Wrogemann K. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am. J. Hum. Genet. 70 (2002) 663-672
12. Duan Z., Gao B., Xu W., and Xiong S. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 374 (2008) 502-506
13. Ogawa S., Goto W., Orimo A., Hosoi T., Ouchi Y., Muramatsu M., and Inoue S. Molecular cloning of a novel RING finger-B box-coiled coil (RBCC) protein, Terf, expressed in the testis. Biochem. Biophys. Res. Commun. 251 (1998) 515-519
14. Boutou E., Matsas R., and Mamalaki A. Isolation of a mouse brain cDNA expressed in developing neuroblasts and mature neurons. Brain Res. Mol. Brain Res. 86 (2001) 153-167
15. Short K.M., Hopwood B., Yi Z., and Cox T.C. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, To microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol. 3 (2002) 1
16. Li Z., Na X., Wang D., Schoen S.R., Messing E.M., and Wu G. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 277 (2002) 4656-4662
17. Li Z., Wang D., Na X., Schoen S.R., Messing E.M., and Wu G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Biochem. Biophys. Res. Commun. 294 (2002) 700-709
18. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., and Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416 (2002) 648-653
19. Curcio-Morelli C., Zavacki A.M., Christofollete M., Gereben B., de Freitas B.C., Harney J.W., Li Z., Wu G., and Bianco A.C. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112 (2003) 189-196
20. Li Z., Wang D., Messing E.M., and VHL G.Wu. protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha. EMBO Rep. 6 (2005) 373-378
21. Kong H.J., Anderson D.E., Lee C.H., Jang M.K., Tamura T., Tailor P., Cho H.K., Cheong J., Xiong H., Morse H.C., and Ozato K. Autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 179 (2007) 26-30
22. Higgs R., Ní Gabhann J., Ben Larbi N., Breen E.P., Fitzgerald K.A., and Jefferies C.A. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181 (2008) 1780-1786